文献速递主动脉疾病

Embo-EVAR预防II型内漏的单中心经验

Embo-EVAR: A Technique to Prevent Type II Endoleak? A Single-Center Experience.
PubMed 文献 · Ann Vasc Surg · 2017-05-04

该单中心回顾性分析比较了72例EVAR患者,其中36例经典EVAR(A组)与36例联合瘤囊栓塞(embo-EVAR,B组),随访6和12个月。B组技术成功率100%,无并发症和死亡;A组9例II型内漏,B组2例。embo-EVAR或可预防II型内漏,但需随机研究验证。

要点

  • embo-EVAR在EVAR术中栓塞瘤囊,技术成功率达100%
  • 随访6和12个月,B组II型内漏2例,A组9例
  • B组平均辐射时间43.3分钟,长于A组的30.3分钟

核心结论

  • embo-EVAR可能有效预防II型内漏及后续并发症,但需随机研究证实。
  • 轻度费用和辐射剂量增加可接受,以避免再次干预。

研究设计与样本

  • 单中心回顾性临床病例分析,纳入2011-2014年72例EVAR患者。
  • A组36例经典EVAR,B组36例embo-EVAR,随访6和12个月行CTA和CEUS。

主要发现

  • B组技术成功率100%,无手术转换,无早期或晚期并发症,死亡率零。
  • A组9例II型内漏和1例Ia型内漏,B组2例II型内漏和1例Ib型内漏。
  • B组平均辐射暴露时间43.3分钟,A组30.3分钟。
  • EVAR手术平均费用9,000€,瘤囊栓塞平均费用1,500€。

关键数值与推荐

  • B组患者均在Δ压力比(Δ瘤囊压力/Δ differential pressure)>0.16时行embo-EVAR。
  • 栓塞使用弹簧圈尽可能填充瘤囊,并注射纤维蛋白胶完成。

临床怎么用

  • 对于接受EVAR的患者,可考虑术中行瘤囊栓塞以预防II型内漏。
  • 需权衡辐射暴露和费用增加与避免再次干预的获益。

局限性

  • 回顾性单中心设计,样本量有限。
  • 需随机研究进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intraprocedural aneurysm sac embolization (embo-EVAR) during endovascular abdominal aneurysm repair (EVAR) using coils and fibrin glue is a technique for preventing type II endoleak (EII). Our aim is to evaluate feasibility, safety and clinical outcome of this promising approach. MATERIALS AND METHODS: A retrospective clinical case analysis of 72 patients who underwent EVAR during the period 2011-2014. Two groups were compared at 6 and 12 months follow-up with contrast media computed tomography scan and contrast-enhanced ultrasound (CEUS) imaging: consecutively, 36 patients (group A) treated with classic EVAR and 36 patients (group B) treated with embo-EVAR. Coils were released filling better as possible the aneurysm sac; the embolization was completed by injecting fibrin glue. Device and materials used, differential systemic and sac pressures, presence of any endoleak, and complication were registered. RESULTS: In our experience, we had 100% technical success without surgical conversion. Embo-EVAR was performed, after endograft deployment, in group B patients, all with ratio of Δ-pressures (obtained from Δ-sac pressure/Δ-differential pressure) > 0.16. No early or late complications occurred and mortality was nil. Follow-up was performed with computed tomography-angiography and CEUS at 6 and 12 months. We observed 9 type II and 1 type Ia endoleak in group A and 2 type II and 1 type Ib endoleaks in group B. Mean radiation exposure time was 30.3 min in group A and 43.3 min in group B. EVAR procedure average cost was 9,000 €. The average cost of sac embolization was 1,500€. CONCLUSIONS: Although a randomized study is necessary, embo-EVAR may be a valid approach to prevent type II endoleaks and further complications. Mild costs and exposure-dose increase could be accepted to avoid reinterventions, and in our experience, it could be routinely performed with excellent results.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Natrella M, Rapellino A, Navarretta F, et al. Embo-EVAR: A Technique to Prevent Type II Endoleak? A Single-Center Experience. Ann Vasc Surg. 2017. PMID: 28479464. doi:10.1016/j.avsg.2017.01.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。